StockData
BioMarin Pharmaceutical Inc logo

BioMarin Pharmaceutical Inc (BMRN) stock

BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3093% above fair value
$61.43+2.92 (+4.99%)

Close on Nov 18, 2026Market cap $11.89BP/E 161.7Yield –

BioMarin Pharmaceutical total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

BioMarin Pharmaceutical's total debt was $4.19B at Jun 30, 2026. For fiscal 2025 it was $597.18M.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$597.18M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.19B–
Q4 FY2025Dec 31, 2025$597.18M–

More BioMarin Pharmaceutical figures

See a number that looks wrong?